Efficacy and safety of intravenous imatinib in COVID-19 ARDS: a randomized, double-blind, placebo-controlled clinical trial

被引：0
|
作者：
Leila N. Atmowihardjo
Job R. Schippers
Erik Duijvelaar
Imke H. Bartelink
Pierre M. Bet
Noortje E. L. Swart
Nienke van Rein
Keith Purdy
David Cavalla
Andrew McElroy
Sarah Fritchley
Anton Vonk Noordegraaf
Henrik Endeman
Patricia van Velzen
Matty Koopmans
Harm Jan Bogaard
Leo Heunks
Nicole Juffermans
Marcus J. Schultz
Pieter R. Tuinman
Lieuwe D. J. Bos
Jurjan Aman
机构：
[1] Amsterdam UMC Location University of Amsterdam,Intensive Care
[2] Amsterdam University Medical Centers,Department of Pulmonary Medicine
[3] Location VUmc,Department of Clinical Pharmacology and Pharmacy
[4] Amsterdam UMC Location Vrije Universiteit Amsterdam,Department of Clinical Pharmacology and Pharmacy
[5] Amsterdam UMC Location University of Amsterdam,Department of Clinical Pharmacology and Pharmacy
[6] Leiden UMC,Intensive Care
[7] Exvastat,Intensive Care
[8] Erasmus University Medical Centre,Intensive Care
[9] Dijklander Hospital,Mahidol Oxford Tropical Medicine Research Unit (MORU)
[10] Location Purmerend,Nuffield Department of Medicine
[11] OLVG Hospital Location Oost,Department of Research and Development
[12] Mahidol University,Intensive Care
[13] University of Oxford,Laboratory of Translational Intensive Care
[14] Hamilton Medical AG,undefined
[15] Amsterdam UMC Location Vrije Universiteit Amsterdam,undefined
[16] Erasmus University,undefined
来源：
Critical Care | / 27卷
关键词：
COVID-19; ARDS; Imatinib; Vascular permeability; Endothelial barrier dysfunction; Pulmonary edema;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Efficacy of Licorice as Adjunctive Therapy in Critically Ill Patients with COVID-19: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial
    Alikiaie, Babak
    Shalamzari, Seyed Mohammad Hosseinian
    Soltani, Rasool
    Yegdaneh, Afsaneh
    Mousavi, Sarah
    JOURNAL OF RESEARCH IN PHARMACY PRACTICE, 2023, 12 (04) : 141 - 147
  • [22] RAMIC: Design of a randomized, double-blind, placebo-controlled trial to evaluate the efficacy of ramipril in patients with COVID-19
    Ajmera, Veeral
    Thompson, Wesley K.
    Smith, Davey M.
    Malhotra, Atul
    Mehta, Ravindra L.
    Tolia, Vaishal
    Yin, Jeffrey
    Sriram, Krishna
    Insel, Paul A.
    Collier, Summer
    Richards, Lisa
    Loomba, Rohit
    CONTEMPORARY CLINICAL TRIALS, 2021, 103
  • [23] Efficacy of amantadine in patients hospitalized with COVID-19: Study protocol of a randomized, double-blind, placebo-controlled trial
    Lopiano, Leonardo
    Artusi, Carlo Alberto
    Bozzali, Marco
    Ancidoni, Antonio
    Ciccone, Giovannino
    De Rosa, Francesco
    Vanacore, Nicola
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [24] CLINICAL EFFICACY OF INTRAVENOUS LIDOCAINE FOR THYROIDECTOMY: A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL.
    Oh, J.
    Choi, G. J.
    Kang, H.
    Baek, C.
    Jung, Y. H.
    Ko, J. S.
    ANESTHESIA AND ANALGESIA, 2016, 123 : 573 - 573
  • [25] Efficacy and safety of Treamid in the rehabilitation of patients after COVID-19 pneumonia: a phase 2, randomized, double-blind, placebo-controlled trial
    Bazdyrev, Evgeny
    Panova, Maria
    Brachs, Maria
    Smolyarchuk, Elena
    Tsygankova, Daria
    Gofman, Liudmila
    Abdyusheva, Yana
    Novikov, Fedor
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [26] Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: a double-blind, placebo-controlled randomized clinical trial
    Berta Grau-Pujol
    Daniel Camprubí-Ferrer
    Helena Marti-Soler
    Marc Fernández-Pardos
    Clara Carreras-Abad
    Maria Velasco-de Andrés
    Elisabet Ferrer
    Magdalena Muelas-Fernandez
    Sophie Jullien
    Giuseppe Barilaro
    Sara Ajanovic
    Isabel Vera
    Laura Moreno
    Eva Gonzalez-Redondo
    Núria Cortes-Serra
    Montserrat Roldán
    Ana Artes-de Arcos
    Isabel Mur
    Pere Domingo
    Felipe Garcia
    Caterina Guinovart
    Jose Muñoz
    Trials, 22
  • [27] Efficacy and safety of Treamid in the rehabilitation of patients after COVID-19 pneumonia: a phase 2, randomized, double-blind, placebo-controlled trial
    Evgeny Bazdyrev
    Maria Panova
    Maria Brachs
    Elena Smolyarchuk
    Daria Tsygankova
    Liudmila Gofman
    Yana Abdyusheva
    Fedor Novikov
    Journal of Translational Medicine, 20
  • [28] A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Alpha-1 Antitrypsin for ARDS Secondary to Severe COVID-19
    Mcelvaney, O.
    McEvoy, N.
    Boland, F.
    Mcelvaney, O. F.
    Hogan, G.
    Donnelly, K.
    Friel, O.
    Clarke, J.
    Fraughen, D.
    Murphy, M. P.
    Carroll, T. P.
    Geoghegan, P.
    Martin-Loeches, I.
    Mcelvaney, N. G.
    Curley, G. F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [29] Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: a double-blind, placebo-controlled randomized clinical trial
    Grau-Pujol, Berta
    Camprubi-Ferrer, Daniel
    Marti-Soler, Helena
    Fernandez-Pardos, Marc
    Carreras-Abad, Clara
    Velasco-de Andres, Maria
    Ferrer, Elisabet
    Muelas-Fernandez, Magdalena
    Jullien, Sophie
    Barilaro, Giuseppe
    Ajanovic, Sara
    Vera, Isabel
    Moreno, Laura
    Gonzalez-Redondo, Eva
    Cortes-Serra, Nuria
    Roldan, Montserrat
    Artes-de Arcos, Ana
    Mur, Isabel
    Domingo, Pere
    Garcia, Felipe
    Guinovart, Caterina
    Munoz, Jose
    TRIALS, 2021, 22 (01)
  • [30] Mycobacterium vaccae Nebulization in the Treatment of COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial
    Lin, Yan-rong
    Wu, Feng-yao
    Xiao, Huan
    Huang, Jian-lin
    Gong, Bei-bei
    Li, You-ling
    Lu, Ning
    Jiang, Xiao-hong
    Sun, Qi-xiang
    Zhang, Jian-feng
    Hu, Jun-tao
    Zhao, Yong-xiang
    Li, Chao-qian
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2021, 34 (02) : 108 - 114
12345